
ZYDUSLIFEZydus Lifesciences Ltd.
Zydus Lifesciences Q2 FY27 Results: Consolidated Net Profit ₹928 Crore on Total Income of ₹8,040 Crore
Zydus Lifesciences (NSE: ZYDUSLIFE) reported consolidated total income of ₹8,040 crore and net profit of ₹928 crore for the quarter ended 30 Sep 2026, it said in a filing on 04 Nov 2026. Standalone total income was ₹3,647 crore and standalone net profit ₹715 crore for the same quarter.
- Earnings
- Pharmaceuticals
